Jasper Therapeutics Inc Asset Resilience Ratio

Latest as of March 2020: 53.37%

Jasper Therapeutics Inc asset resilience ratio. Jasper Therapeutics Inc (JSPR) has an Asset Resilience Ratio of 53.37% as of March 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See JSPR defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$54.33 Million

Cash + Short-term Investments

Total Assets

$101.79 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Jasper Therapeutics Inc (None–None)

Asset resilience ratio of Jasper Therapeutics Inc from None to None. This chart shows how Jasper Therapeutics Inc's Asset Resilience Ratio has changed over time. Read JSPR total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jasper Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Jasper Therapeutics Inc total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$54.33 Million	53.37%
Total Liquid Assets	$54.33 Million	53.37%

Asset Resilience Insights

Very High Liquidity: Jasper Therapeutics Inc maintains exceptional liquid asset reserves at 53.37% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jasper Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Jasper Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Jasper Therapeutics Inc Asset Resilience Ratio by Year (None–None)

Jasper Therapeutics Inc asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Jasper Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Jasper Therapeutics Inc

NASDAQ:JSPR USA Biotechnology

Market Cap

$15.97 Million

Market Cap Rank

#25632 Global

#5413 in USA

Share Price

$0.48

Change (1 day)

-5.51%

52-Week Range

$0.34 - $2.05

All Time High

$164.20